A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer
Clinical trial NCT02409199 · UNKNOWN
Trial details
- NCT number
- NCT02409199
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-06-01
- Primary completion
- 2016-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.